Cargando…

Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects

Detalles Bibliográficos
Autores principales: Mosconi, Maria Giulia, Caso, Francesco, Maraziti, Giorgio, Kremer, Christine, Costa, Luisa, Scarpa, Raffaele, Giacomelli, Roberto, Caso, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491439/
https://www.ncbi.nlm.nih.gov/pubmed/34609661
http://dx.doi.org/10.1007/s10072-021-05620-5
_version_ 1784578741671821312
author Mosconi, Maria Giulia
Caso, Francesco
Maraziti, Giorgio
Kremer, Christine
Costa, Luisa
Scarpa, Raffaele
Giacomelli, Roberto
Caso, Valeria
author_facet Mosconi, Maria Giulia
Caso, Francesco
Maraziti, Giorgio
Kremer, Christine
Costa, Luisa
Scarpa, Raffaele
Giacomelli, Roberto
Caso, Valeria
author_sort Mosconi, Maria Giulia
collection PubMed
description
format Online
Article
Text
id pubmed-8491439
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84914392021-10-05 Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects Mosconi, Maria Giulia Caso, Francesco Maraziti, Giorgio Kremer, Christine Costa, Luisa Scarpa, Raffaele Giacomelli, Roberto Caso, Valeria Neurol Sci News and Views Springer International Publishing 2021-10-05 2021 /pmc/articles/PMC8491439/ /pubmed/34609661 http://dx.doi.org/10.1007/s10072-021-05620-5 Text en © Fondazione Società Italiana di Neurologia 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News and Views
Mosconi, Maria Giulia
Caso, Francesco
Maraziti, Giorgio
Kremer, Christine
Costa, Luisa
Scarpa, Raffaele
Giacomelli, Roberto
Caso, Valeria
Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects
title Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects
title_full Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects
title_fullStr Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects
title_full_unstemmed Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects
title_short Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects
title_sort autoimmune screening before adenovirus vector-based dna vaccine in women may avoid underuse for all the subjects
topic News and Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491439/
https://www.ncbi.nlm.nih.gov/pubmed/34609661
http://dx.doi.org/10.1007/s10072-021-05620-5
work_keys_str_mv AT mosconimariagiulia autoimmunescreeningbeforeadenovirusvectorbaseddnavaccineinwomenmayavoidunderuseforallthesubjects
AT casofrancesco autoimmunescreeningbeforeadenovirusvectorbaseddnavaccineinwomenmayavoidunderuseforallthesubjects
AT marazitigiorgio autoimmunescreeningbeforeadenovirusvectorbaseddnavaccineinwomenmayavoidunderuseforallthesubjects
AT kremerchristine autoimmunescreeningbeforeadenovirusvectorbaseddnavaccineinwomenmayavoidunderuseforallthesubjects
AT costaluisa autoimmunescreeningbeforeadenovirusvectorbaseddnavaccineinwomenmayavoidunderuseforallthesubjects
AT scarparaffaele autoimmunescreeningbeforeadenovirusvectorbaseddnavaccineinwomenmayavoidunderuseforallthesubjects
AT giacomelliroberto autoimmunescreeningbeforeadenovirusvectorbaseddnavaccineinwomenmayavoidunderuseforallthesubjects
AT casovaleria autoimmunescreeningbeforeadenovirusvectorbaseddnavaccineinwomenmayavoidunderuseforallthesubjects